Pacific Biosciences (PACB) Upgraded to Buy: Here’s What You Should Know
ZacksPacific Biosciences (PACB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.